Preliminary results of a accelerated dose escalation phase I trial with a novel anthracycline derivative (RTA-744) in patients with primary brain tumors

被引：0
|
作者：
Conrad, C. A.
Madden, T.
Meyer, C.
Preibe, W.
Baud, C.
Fokt, I.
Gilbert, M.
Groves, M.
Levin, V.
Yung, W. K. A.
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Reata Pharmaceut Inc, Dallas, TX USA
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70135-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
129
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] Results of a phase I trial with the novel anthracycline derivative RTA 744 in patients with recurrent primary brain tumors
    Conrad, Charles
    Maher, Elizabeth
    Cloughesy, Timothy
    Fink, Karen
    Priebe, Waldemar
    Madden, Timothy
    Meyer, Colin
    Foster, Paul
    Groves, Morris
    Gilbert, Mark
    Levin, Victor
    Puduvalli, Vinay
    Colman, Howard
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2007, 9 (04) : 523 - 524
  • [2] Final results of a phase I trial with the novel anthracycline derivative RTA 744 in patients with primary brain tumors
    Conrad, C. A.
    Maher, E.
    Cloughesy, T.
    Groves, M.
    Gilbert, M.
    Madden, T.
    Levin, V.
    Priebe, W.
    Meyer, C.
    Yung, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Preliminary phase I results of the novel anthracycline RTA 744 in patients with primary brain tumors
    Conrad, Charles
    Meyers, Christina
    Madden, Timothy
    Priebe, Waldemar
    Gaupp, Patricia
    Rohan, Karen
    Baud, Christiane
    NEURO-ONCOLOGY, 2006, 8 (04) : 440 - 440
  • [4] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [5] Phase I dose escalation trial of pegzilarginase in patients with advanced solid tumors
    Rasco, Drew W.
    Eckhardt, S. Gail
    Davar, Diwakar
    Lewis, Karl
    Lara-Guerra, Humberto
    Alters, Susan E.
    Eckert, Stephen
    Rowlinson, Scott W.
    Wooldridge, James E.
    Carvajal, Richard D.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal Tumors
    Kaplan, I. D.
    Redrosa, I.
    Martin, C.
    Collins, C.
    Wagner, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S191 - S191
  • [7] Results of a Phase I Trial of Dose Escalation for Preoperative Stereotactic Radiosurgery for Patients with Large Brain Metastases
    Murphy, E. S.
    Yang, K.
    Suh, J. H.
    Yu, J. S.
    Stevens, G.
    Angelov, L.
    Vogelbaum, M.
    Barnett, G. H.
    Ahluwalia, M.
    Neyman, G.
    Mohammadi, A. M.
    Chao, S. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S73 - S74
  • [8] Phase I trial of lurbinectedin (PM1183) in Japanese patients with advanced tumors: Results of the dose escalation part.
    Takahashi, Shunji
    Shimizu, Toshio
    Doi, Toshihiko
    Lopez-Vilarino, Jose Antonio
    Nunez, Rafael
    Kahatt, Carmen Maria
    Fernandez, Carlos
    Zaragoza, Katrin
    Sasamoto, Hiromi
    Soto-Matos, Arturo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial)
    Baldini, C.
    Danlos, F-X.
    Varga, A.
    Halse, H.
    Mouraud, S.
    Cassard, L.
    Bredel, D.
    Escriou, G.
    Parpaleix, A.
    Rafie, S.
    Abbassi, A. E.
    Laghouati, S.
    Farhane, S.
    Tselikas, L.
    Texier, M.
    Adam, J.
    Chaput, N.
    Soria, J-C.
    Massard, C.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S842 - S843
  • [10] Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases
    Murphy, Erin S.
    Yang, Kailin
    Suh, John H.
    Yu, Jennifer S.
    Stevens, Glen
    Angelov, Lilyana
    Vogelbaum, Michael A.
    Barnett, Gene H.
    Ahluwalia, Manmeet S.
    Neyman, Gennady
    Mohammadi, Alireza M.
    Chao, Samuel T.
    NEURO-ONCOLOGY, 2024, 26 (09) : 1651 - 1659
12345